TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T92653	Neuropeptide Y receptor type 2	B0JAI2	2-Diphenylacetylamino-5-guanidino-pentanoic acid [1-(4-hydroxy-phenyl)-ethyl]-amide	Investigative	44288112	C28H33N5O3	487.6	CC(C1=CC=C(C=C1)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3	IC50 = 575000 nM	Non binder
T92653	Neuropeptide Y receptor type 2	B35VLW	2-Diphenylacetylamino-5-guanidino-pentanoic acid ((S)-2-hydroxy-1-phenyl-ethyl)-amide	Investigative	44287971	C28H33N5O3	487.6	C1=CC=C(C=C1)[C@@H](CO)NC(=O)C(CCCN=C(N)N)NC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3	IC50 = 540000 nM	Non binder
T92653	Neuropeptide Y receptor type 1	B40DXV	N-(6-(2-(5-Ethyl-4-methyloxazol-2-yl)ethyl)-4-morpholinopyridin-2-yl)acetamide	Investigative	45269119	C19H26N4O3	358.4	CCC1=C(N=C(O1)CCC2=NC(=CC(=C2)N3CCOCC3)NC(=O)C)C	IC50 = 320000 nM	Non binder
T92653	Neuropeptide Y receptor type 2	B57TIV	N-[4-Guanidino-1-(7-hydroxy-1,3,4,5-tetrahydro-benzo[c]azepine-2-carbonyl)-butyl]-2,2-diphenyl-acetamide	Investigative	44288067	C30H35N5O3	513.6	C1CC2=C(CN(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(C3=CC=CC=C3)C4=CC=CC=C4)C=CC(=C2)O	IC50 = 247000 nM	Non binder
T92653	Neuropeptide Y receptor type 2	B9BLS5	2-Diphenylacetylamino-5-guanidino-pentanoic acid ((R)-carbamoyl-phenyl-methyl)-amide	Investigative	44287982	C28H32N6O3	500.6	C1=CC=C(C=C1)[C@H](C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3	IC50 > 400000 nM	Non binder
T92653	Neuropeptide Y receptor type 1	BSRK79	2-(6-((4,5-Dimethyloxazol-2-yloxy)methyl)-4-morpholinopyridin-2-ylamino)acetonitrile	Investigative	45267391	C17H21N5O3	343.4	CC1=C(OC(=N1)OCC2=NC(=CC(=C2)N3CCOCC3)NCC#N)C	IC50 > 1000000 nM	Non binder